News & Updates

Show Multimedia Only

Novel mRNA-based vaccine prevents flu infection in adults

17 Nov 2025 by

The novel mRNA-based influenza vaccine mRNA-1010 has demonstrated superior efficacy over its standard-dose (SD) comparator in preventing RT-PCR–confirmed protocol-defined influenza disease in adults aged 50 years and above, reports a study presented at IDWeek 2025.

Novel mRNA-based vaccine prevents flu infection in adults

17 Nov 2025

Infection risk higher in adalimumab users with HS vs psoriasis

16 Nov 2025

Among adults receiving adalimumab treatment, those with hidradenitis suppurativa appear to be at greater risk of infection than their psoriasis counterparts, as reported in a retrospective study.

Infection risk higher in adalimumab users with HS vs psoriasis

16 Nov 2025

Large French study clears mRNA-based COVID-19 vaccines of teratogenic risk

15 Nov 2025 by

Receipt of messenger RNA (mRNA)-based COVID-19 vaccine during pregnancy does not appear to be associated with an increased risk of any major congenital malformations, according to new research from France.

Large French study clears mRNA-based COVID-19 vaccines of teratogenic risk

15 Nov 2025

DS-5670d vaccine against COVID-19 not inferior to BNT162b2

14 Nov 2025 by

A single dose of the omicron XBB.1.5-targeting COVID-19 mRNA vaccine DS-5670d demonstrates immunogenic non-inferiority to BNT162b2 in individuals with or without a history of prior SARS-CoV-2 infection or COVID-19 vaccination, reports a study.

DS-5670d vaccine against COVID-19 not inferior to BNT162b2

14 Nov 2025

Invasive mould disease: A critical concern for immunocompromised patients

14 Nov 2025

During the recent Masterclass in Infectious Disease Summit Programme (MISP) Season 2, sponsored by Pfizer, Dr Asok Kurup, an infectious disease physician and chair of the Infection Control Committee at Mount Elizabeth, Singapore, discussed treatment challenges in invasive mould disease (IMD), guideline recommendations, the role of isavuconazole, and antifungal stewardship to combat antifungal resistance.

Invasive mould disease: A critical concern for immunocompromised patients

14 Nov 2025

Short-course nafithromycin noninferior to 7-day moxifloxacin regimen for pneumonia

11 Nov 2025 by

A 3-day course of oral nafithromycin is equally efficacious as the 7-day course of oral moxifloxacin for the treatment of community-acquired bacterial pneumonia (CABP) in adults, as shown in a phase III study.

Short-course nafithromycin noninferior to 7-day moxifloxacin regimen for pneumonia

11 Nov 2025

Post-exertional malaise prevalent in adults with long COVID

10 Nov 2025 by

A systematic review and meta-analysis reports a high prevalence of post-exertional malaise (PEM) in individuals with post-COVID-19 condition (PCC).

Post-exertional malaise prevalent in adults with long COVID

10 Nov 2025

Long-term LVEF decline occurs following COVID-19

08 Nov 2025 by

Individuals with SARS‐CoV‐2 infection, especially those who are hospitalized, face long‐term declines in left ventricular ejection fraction (LVEF), according to a retrospective study.

Long-term LVEF decline occurs following COVID-19

08 Nov 2025

Patients with serious mental illness at high risk of postacute sequelae of SARS-CoV-2

06 Nov 2025

Among patients who sustained COVID-19 infection, the risk of postacute sequelae of SARS-CoV-2 (PASC) is high in the presence of a serious mental illness, according to a study.

Patients with serious mental illness at high risk of postacute sequelae of SARS-CoV-2

06 Nov 2025

Dengue may increase susceptibility to subsequent cardiac events

06 Nov 2025 by

Individuals who sustained an acute dengue virus infection are predisposed to cardiovascular events up to 30 days after infection, although the excess risk was modest, according to a study from Singapore.

Dengue may increase susceptibility to subsequent cardiac events

06 Nov 2025

News & Updates

Filter by Specialty:

Specialty:

Novel mRNA-based vaccine prevents flu infection in adults

Novel mRNA-based vaccine prevents flu infection in adults

Infection risk higher in adalimumab users with HS vs psoriasis

Infection risk higher in adalimumab users with HS vs psoriasis

Large French study clears mRNA-based COVID-19 vaccines of teratogenic risk

Large French study clears mRNA-based COVID-19 vaccines of teratogenic risk

DS-5670d vaccine against COVID-19 not inferior to BNT162b2

DS-5670d vaccine against COVID-19 not inferior to BNT162b2

Invasive mould disease: A critical concern for immunocompromised patients

Invasive mould disease: A critical concern for immunocompromised patients

Short-course nafithromycin noninferior to 7-day moxifloxacin regimen for pneumonia

Short-course nafithromycin noninferior to 7-day moxifloxacin regimen for pneumonia

Post-exertional malaise prevalent in adults with long COVID

Post-exertional malaise prevalent in adults with long COVID

Long-term LVEF decline occurs following COVID-19

Long-term LVEF decline occurs following COVID-19

Patients with serious mental illness at high risk of postacute sequelae of SARS-CoV-2

Patients with serious mental illness at high risk of postacute sequelae of SARS-CoV-2

Dengue may increase susceptibility to subsequent cardiac events

Dengue may increase susceptibility to subsequent cardiac events